Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Karla KerlikowskeDiana L Miglioretti

Abstract

We determined whether the association between breast density and breast cancer risk and cancer severity differs according to menopausal status and postmenopausal hormone therapy (HT) use. We collected data on 587,369 women who underwent 1,349,027 screening mammography examinations; 14,090 women were diagnosed with breast cancer. We calculated 5-year breast cancer risk from a survival model for subgroups of women classified by their Breast Imaging Reporting and Data System (BIRADS) breast density, age, menopausal status, and current HT use, assuming a body mass index of 25 kg/m(2). Odds of advanced (ie, IIb, III, IV) versus early (ie, I, IIa) stage invasive cancer was calculated according to BIRADS density. Breast cancer risk was low among women with low density (BIRADS-1): women age 55 to 59 years, 5-year risk was 0.8% (95% CI, 0.6 to 0.9%) for non-HT users and 0.9% (95% CI, 0.7% to 1.1%) for estrogen and estrogen plus progestin users. Breast cancer risk was high among women with very high density (BIRADS-4), particularly estrogen plus progestin users: women age 55 to 59 years, 5-year risk was 2.4% (95% CI, 2.0% to 2.8%) for non-HT users, 3.0% (95% CI, 2.6% to 3.5%) for estrogen users, and 4.2% (95% CI, 3.7% to 4.6%) for estrog...Continue Reading

References

Jan 1, 1992·Breast Cancer Research and Treatment·J RussoI H Russo
Nov 1, 1995·Journal of the National Cancer Institute·C ByrneR Haile
Oct 6, 1997·AJR. American Journal of Roentgenology·R Ballard-BarbashL G Kessler
Jan 6, 2001·Cancer Causes & Control : CCC·A Y El-BastawissiS H Taplin
Feb 15, 2001·JAMA : the Journal of the American Medical Association·C M RutterS Taplin
Sep 20, 2002·The New England Journal of Medicine·Norman F BoydJohn L Hopper
Oct 17, 2002·Journal of the National Cancer Institute·Virginia L ErnsterBerta M Geller
Jan 2, 2003·Journal of the National Cancer Institute·Gail A GreendaleGiske Ursin
Jun 26, 2003·JAMA : the Journal of the American Medical Association·Rowan T ChlebowskiUNKNOWN WHI Investigators
Dec 4, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Karla KerlikowskePatricia A Carney
Apr 22, 2004·Journal of the National Cancer Institute·Jack CuzickStephen W Duffy
Mar 1, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Tong LiNorman Boyd
Mar 16, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Erin J AielloPeggy L Porter
Jul 14, 2005·Biometrics·Yingye Zheng, Patrick J Heagerty
Aug 9, 2005·The Breast : Official Journal of the European Society of Mastology·S CiattoA Scorsolini
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Marcia L StefanickUNKNOWN WHI Investigators
May 17, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Norman F BoydSalomon Minkin
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Valerie A McCormack, Isabel dos Santos Silva
Nov 16, 2006·Journal of the National Cancer Institute·Tia R MilaneseDaniel W Visscher
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fränzel J B van DuijnhovenCarla H van Gils
Mar 8, 2007·Journal of the National Cancer Institute·Karla KerlikowskeUNKNOWN National Institutes of Health Breast Cancer Surveillance Consortium
Apr 10, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Karthik GhoshCeline M Vachon
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anne McTiernanGerardo Heiss

❮ Previous
Next ❯

Citations

Apr 5, 2013·JAMA Internal Medicine·Karla KerlikowskeUNKNOWN Breast Cancer Surveillance Consortium
Jun 18, 2011·Breast Cancer Research and Treatment·Jennifer S HaasKathryn A Phillips
Aug 31, 2011·Breast Cancer Research and Treatment·Karthik GhoshCeline M Vachon
Jan 10, 2012·Breast Cancer Research and Treatment·Christy G WoolcottGertraud Maskarinec
Jul 21, 2012·Breast Cancer Research and Treatment·Lusine YaghjyanKathleen Wolin
Aug 7, 2012·Breast Cancer Research and Treatment·Hilda RazzaghiRobert C Millikan
Apr 5, 2011·Cancer Causes & Control : CCC·Brooke M WinzerJennifer D Paratz
Oct 11, 2011·Cancer Causes & Control : CCC·Lusine YaghjyanBettina Drake
Aug 3, 2011·Nature Reviews. Clinical Oncology·Steven A Narod
Jul 29, 2011·Journal of the National Cancer Institute·Lusine YaghjyanRulla M Tamimi
Jul 29, 2011·Journal of the National Cancer Institute·Karla Kerlikowske, Amanda I Phipps
Aug 23, 2012·Journal of the National Cancer Institute·Gretchen L GierachMark E Sherman
Jun 8, 2013·Journal of the National Cancer Institute·Jeffrey A TiceKarla Kerlikowske
Sep 5, 2013·Journal of the National Cancer Institute·Ningqi HouDezheng Huo
Sep 5, 2013·Journal of the National Cancer Institute·Mary Beth Terry, Parisa Tehranifar
Nov 26, 2011·Breast Cancer Research : BCR·Norman F BoydSalomon Minkin
Jan 27, 2012·Breast Cancer Research : BCR·John A Shepherd, Karla Kerlikowske
May 2, 2012·Annals of Internal Medicine·Heidi D NelsonDiana L Miglioretti
Dec 7, 2013·Journal of the National Cancer Institute·Karen J WernliDiana S M Buist
Mar 13, 2014·Breast Cancer Research and Treatment·C W HuoE W Thompson
Jun 3, 2014·Surgical Oncology Clinics of North America·Kristen A Ban, Constantine V Godellas
Jul 9, 2014·Semergen·P VichE Redondo-Margüello
Jun 1, 2014·Medical Physics·Xing ZhangXiaojun Liu
Oct 18, 2013·Current Osteoporosis Reports·Palak ChoksiCatherine Van Poznak
Feb 9, 2013·Journal of Mammary Gland Biology and Neoplasia·Leena Hilakivi-ClarkeAnni Warri
Apr 23, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lusine YaghjyanRulla M Tamimi
Jan 23, 2013·Climacteric : the Journal of the International Menopause Society·H Kuhl, H P G Schneider
May 16, 2013·Climacteric : the Journal of the International Menopause Society·T J de VilliersUNKNOWN International Menopause Society
Nov 26, 2015·Climacteric : the Journal of the International Menopause Society·M Aparecida SantosA Ferraz Carbonel
Aug 13, 2013·Climacteric : the Journal of the International Menopause Society·M A SantosR D Reginato
May 23, 2012·Climacteric : the Journal of the International Menopause Society·A Gompel, R J Santen
May 14, 2011·Climacteric : the Journal of the International Menopause Society·D W SturdeeJ C Stevenson
Apr 2, 2014·Mayo Clinic Proceedings·Amy T WangKarthik Ghosh
Nov 12, 2013·La Presse médicale·Anne Gompel
Sep 18, 2012·Maturitas·J DesreuxE Lifrange
Nov 23, 2012·The New England Journal of Medicine·Robert A SmithMette Kalager
Sep 6, 2011·Endocrinology and Metabolism Clinics of North America·Wendy Y Chen
Dec 4, 2015·Medical Physics·Kwan-Hoong Ng, Susie Lau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.